buserelin has been researched along with trelstar in 110 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 32 (29.09) | 18.7374 |
1990's | 52 (47.27) | 18.2507 |
2000's | 13 (11.82) | 29.6817 |
2010's | 11 (10.00) | 24.3611 |
2020's | 2 (1.82) | 2.80 |
Authors | Studies |
---|---|
Ben-Menahem, D; Hammel, I; Lewy, H; Limor, R; Naor, Z; Shraga, Z; Stein, R | 1 |
Kitroser, H; Levy, J; Schally, AV; Segal-Abramson, T; Sharoni, Y | 1 |
Brower, ST; Hollander, VP; Redding, TW; Schally, AV | 1 |
Alvarez, S; Antoine, JM; Cornet, D; Firmin, C; Mandelbaum, J; Plachot, M; Salat-Baroux, J | 1 |
Cohen, K; Monroziès, X; Oustry, P; Parinaud, J; Perineau, M; Rème, JM | 1 |
Monroziès, X; Oustry, P; Parinaud, J; Perineau, M; Pontonnier, G; Rème, JM | 1 |
Andreoli, C; D'Addato, F; Repinto, A | 1 |
Bukovsky, I; Caspi, E; Golan, A; Koch, Y; Langer, R; Neuman, M | 1 |
Amiel, ML; Benveniste, J; Testart, J | 1 |
Armengol, J; Bella, F; Calaf, J; Espaulella, J; Lain, JM | 1 |
Lauritzen, C; Rossmanith, WG; Sasse, V; Wirth, U | 2 |
Adle, F; Allart, JP; Belaisch-Allart, J; Briot, P; Dufêtre, C; Mussy, MA; Soria, B | 1 |
Abramovici, H; Dirnfeld, M; Goldman, S; Gonen, Y; Koifman, M | 1 |
Ando, M; Nakamura, Y; Nanno, T; Suzuki, M; Ubukata, Y; Yamada, H; Yoshimura, Y | 1 |
Anderson, H; Dodwell, DJ; Howell, A | 1 |
Barlow, DH; Egan, D; Forman, RG; Frydman, R; Ross, C | 1 |
Bourguignon, JP; Franchimont, P; Gérard, A | 1 |
Ashkenazi, J; Dicker, D; Feldberg, D; Goldman, GA; Goldman, JA | 1 |
Bettendorf, G; Braendle, W; Köhler, S; Lichtenberg, V; Lindner, C | 1 |
Bettendorf, G; Braendle, W; Lichtenberg, V; Lindner, C | 2 |
Barg, E; Hirowska, I; Iwanicka, Z; Pellar, J; Wasikowa, R | 1 |
Jacobi, GH | 1 |
Alvarez, S; Antoine, JM; Cornet, D; Firmin, C; Mandelbaum, J; Plachot, M; Salat-Baroux, J; Tibi, C | 1 |
Adelberger, V; Breckwoldt, M; Geisthövel, F; Wieacker, P | 1 |
Ashkenazi, J; Dicker, D; Feldberg, D; Goldman, GA; Goldman, JA; Yeshaya, A | 1 |
Belaisch-Allart, J; Forman, R; Frydman, R; Gazengel, A; Hazout, A; Strubb, N; Testart, J | 1 |
Belaisch-Allart, J; Forman, R; Frydman, R; Hazout, A; Strubb, N; Testart, J; Volante, M | 1 |
Bettendorf, G; Bispink, L; Braendle, W; Lichtenberg, V; Lindner, C | 1 |
Bettendorf, G; Braendle, W; Köhler, S; Lindner, C | 1 |
Hartmann, A; Mann, K | 1 |
Cabranes, JA; Charro, AL; Rubio, MA; Schally, AV | 1 |
Ben-Rafael, Z; Dor, J; Elenbogen, A; Levran, D; Lipitz, S; Mashiach, S; Serr, DM; Shalev, J | 1 |
Braendle, W | 1 |
Lemay, A | 1 |
Bettendorf, G; Braendle, W; Goepel, E; Lichtenberg, V; Lindner, C | 1 |
Holubová, M; Pilka, L; Roztocil, A | 1 |
Hazum, E; Insler, V; Levy, J; Marbach, M; Sharoni, Y; Wiznitzer, A | 1 |
Faure, N; Lemay, A | 1 |
Besser, GM; Hendry, WF; Man, A; Oliver, RT; Paris, AM; Tiptaft, RC; Waxman, J; Whitfield, HN | 1 |
Calle Fernández, JR; Rubio Herrera, MA | 1 |
Ehrenthal, W; Happ, J; Jacobi, GH; Spindler, HW; von Wallenberg, H; Wenderoth, UK | 1 |
Garnick, MB; Seely, JH; Swanson, LJ | 1 |
Claustrat, B; Forest, MG; Lahlou, N; Lejeune, H; Loras, B; Sassolas, G; Trouillas, J | 1 |
Ehrenthal, W; Hohenfellner, R; Jacobi, GH; Spindler, HW; von Wallenberg, H; Wenderoth, UK | 1 |
Belaisch-Allart, J; Forman, R; Frydman, R; Hazout, A; Parneix, I; Testart, J | 1 |
Bahari, C; Blankstein, J; Kokia, E; Lunenfeld, B; Pariente, C; Shadmi, AL | 1 |
Insler, V; Levy, J; Lunenfeld, E; Potashnik, G | 1 |
Belanger, A; Borsanyi, JP; Dupont, A; Emond, J; Giguere, M; Labrie, F; Lacourciere, Y; Monfette, G | 1 |
Bourguignon, JP; Debougnoux, G; Franchimont, P; Gerard, A; Rose, J | 1 |
Jacobi, GH; Wenderoth, UK | 1 |
Belanger, A; Dupont, A; Giguere, M; Labrie, F; Lachance, R | 1 |
Chakraborti, R; Jagannadha Rao, A; Kotagi, SG; Moudgal, NR; Ravindranath, N | 1 |
Bélanger, A; Cusan, L; Kelly, PA; Labrie, F; Lemay, A; Pelletier, G; Raynaud, JP; Reeves, J; Séguin, C | 1 |
Arimura, A; Coy, DH; Schally, AV | 1 |
Ackman, D; Comaru-Schally, AM; Fazekas, AT; Labrie, F; Mehta, A; Schally, AV; Stellos, A; Tolis, G | 1 |
Juul, A; Krabbe, S; Müller, J; Nielsen, CT; Scheike, T; Skakkebaek, NE | 1 |
Coeling-Bennink, H; Devroey, P; Mannaerts, B; Smitz, J; Van Steirteghem, AC | 1 |
Bramley, TA; McPhie, CA; Menzies, GS | 1 |
Antoniazzi, F; Bernasconi, S; Bozzola, M; Cisternino, M; Corrias, A; De Luca, F; De Sanctis, C; Nizzoli, G; Rigon, F; Zamboni, G | 1 |
Van Leusden, HA | 1 |
Bili, H; Bontis, J; Lagos, S; Mantalenakis, S; Tarlatzis, BC; Vatev, I | 1 |
Bourguignon, JP; Craen, M; Fawe, L; Heinrichs, C; Malvaux, P; Vanderschueren-Lodeweyckx, M | 1 |
Feliciani, E; Ferraretti, AP; Fortini, D; Gianaroli, L; Magli, C; Tabanelli, C | 1 |
Barry-Kinsella, C; Cottell, E; Drudy, L; Frankish, A; Gordon, A; Harrison, RF; Hennelly, B; Kondaveeti, U; Unwin, A | 1 |
Drop, SL; Hümmelink, R; Odink, RJ; Oostdijk, W; Partsch, CJ; Sippell, WG | 1 |
Abramovici, H; Dirnfeld, M; Goldman, S; Gonen, Y; Koifman, M; Kraiem, Z; Lissak, A | 1 |
Drop, SL; Hümmelink, R; Odink, RJ; Oostdijk, W; Partsch, CJ; Peter, M; Sippell, WG | 1 |
Arnone, R; Capelli, M; Cognigni, G; Dellai, P; Falbo, A; Filicori, M; Flamigni, C | 1 |
Barnes, KM; Cutler, GB; Hill, S; Jones, J; Manasco, PK; Oerter, KE | 1 |
Hunt, L; Lieberman, BA; Matson, PL; Morroll, DR; Troup, SA; Wada, I | 1 |
Albertsson-Wikland, K; Phillips, DJ; Wide, L | 1 |
Bertrand, E; Devreker, F; Englert, Y; Gervy, C; Govaerts, I; Van den Bergh, M | 1 |
Casper, RF | 1 |
Aspden, WJ; D'Occhio, MJ; Whyte, TR | 1 |
Bühler, K; Gärtner, A; Kuhlmann, M; Regidor, PA; Schindler, AE; Schindler, EM | 1 |
Anserini, P; Capitanio, GL; Gaggero, G; Magnasco, A; Remorgida, V; Testa, D | 1 |
Barash, A; Ben-Arie, A; Manor, M; Milman, D; Shoham, Z; Weissman, A | 1 |
Baroncelli, GI; Bertelloni, S; Perri, G; Saggese, G; Sorrentino, MC | 1 |
Beijnen, JH; Boschma, MU; Bult, A; Hoitink, MA; Underberg, WJ; van der Houwen, OA; Wiese, G | 1 |
Abramovici, H; Ahdut, A; Dirnfeld, M; Fruchter, O; Lissak, A; Yshai, D | 1 |
Ambrose, JD; Rajamahendran, R; Schmitt, EJ; Thatcher, MJ; Thatcher, WW | 1 |
Ambrose, JD; Binelli, M; Diaz, T; Moreira, F; Pires, MF; Thatcher, WW | 1 |
Spiliotis, BE | 1 |
Baroncelli, GI; Bertelloni, S; Ferdeghini, M; Menchini-Fabris, F; Saggese, G | 1 |
Antoniazzi, F; Arrigo, T; Bertelloni, S; Borrelli, P; Cisternino, M; De Luca, F; Galluzzi, F; Mengarda, F; Osio, D; Pasquino, AM; Tatò, L | 1 |
Jarry, H; Leonhardt, S; Luft, H; Roth, C; Seidel, C; Wuttke, W | 1 |
Andersson, AM; Müller, J; Sehested, A; Skakkebaek, NE | 1 |
Emperaire, JC; Parneix, I; Parneix, P; Ruffie, A | 1 |
Mannaerts, BM; Out, HJ | 1 |
Arnold, S; Hubler, M; Jöchle, W; Piché, CA; Reichler, IM; Trigg, TE | 1 |
Bandi, N; Kompella, UB; Koushik, K; Sundaram, S | 1 |
Linder, R; Manna, C; Mohamed, EI; Nardo, LG; Pappalardo, S; Rahman, A; Sbracia, M | 1 |
Aghahosseini, M; Alleyassin, A; Meysamie, A; Mohammadi, FS; Rahimi, E; Safdarian, L | 1 |
Cortell, C; Lavara, R; Marco-Jiménez, F; Vicente, JS; Viudes-de-Castro, MP | 1 |
Camacho, FC; Carrillo, L; D'Occhio, M; Govea, J; Guy, N; Johnston, SD; Lisle, AT; Martinez, O; Parãs, A | 1 |
Carsi, M; Iannazzo, S; Perachino, M; Pradelli, L | 1 |
Bhattacharya, S; Gibreel, A; Maheshwari, A; Siristatidis, CS | 1 |
Fasulkov, I; Georgiev, P; Goericke-Pesch, S; Vodenicharov, A; Wehrend, A | 1 |
Ata, B; Dahan, MH; Polat, M; Seyhan, A; Son, WY; Yarali, H | 1 |
Anikus'ko, NF; Liubota, II; Liubota, RV; Shchepotin, IB; Zotov, AS | 1 |
Duensing, S; Grüllich, C; Hadaschik, BA; Höfner, T; Hohenfellner, M; Jäger, D; Pahernik, S; Vallet, S | 1 |
Braun, J; Daub, L; Geyer, A; Otzdorff, C; Reese, S; Walter, B | 1 |
Basios, G; Bhattacharya, S; Gibreel, A; Maheshwari, A; Siristatidis, CS | 1 |
Braun, J; Daub, L; Geyer, A; Otzdorff, C; Poth, T; Reese, S; Walter, B | 1 |
Čehić, E; Franulić, D; Grgić, F; Kasum, M; Lila, A; Orešković, S; Vujić, G | 1 |
Bruyas, JF; Cochard, A; Dhier, T; Dordas-Perpinyà, M; Frilley, C; Huiban, F; Normandin, L; Terris, H | 1 |
Cicione, A; De Nunzio, C; Franco, A; Gravina, C; Grimaldi, MC; Guercio, A; Lombardo, R; Nacchia, A; Tema, G; Tubaro, A | 1 |
12 review(s) available for buserelin and trelstar
Article | Year |
---|---|
New endocrine approaches to breast cancer.
Topics: Androgen Antagonists; Animals; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteolytic Agents; Progestins; Rats; Somatostatin; Triptorelin Pamoate | 1990 |
Gonadotropin-releasing hormone analogs and prostatic cancer.
Topics: Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Clinical Trials as Topic; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Prostatic Neoplasms; Triptorelin Pamoate | 1988 |
LH-RH agonists and antagonists.
Topics: Animals; Buserelin; Contraception; Female; Fertility; Gonadotropin-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Leuprolide; Male; Ovary; Pregnancy; Triptorelin Pamoate | 1980 |
Impact of different GnRH analogs in benign gynecological disorders related to their chemical structure, delivery systems and dose.
Topics: Buserelin; Dose-Response Relationship, Drug; Drug Delivery Systems; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Leuprolide; Menstrual Cycle; Nafarelin; Structure-Activity Relationship; Triptorelin Pamoate | 1994 |
[Comparison between complete and incomplete suppression of the hypophyseal-gonadal axis in girls with central precocious puberty: effect on growth and prospective final height].
Topics: Age Determination by Skeleton; Body Height; Buserelin; Child; Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Luteinizing Hormone; Multicenter Studies as Topic; Puberty, Precocious; Triptorelin Pamoate | 1993 |
Effects of luteinizing hormone-releasing hormone agonists on final height in luteinizing hormone-releasing hormone-dependent precocious puberty.
Topics: Adult; Age Determination by Skeleton; Age Factors; Body Height; Buserelin; Child; Clinical Trials as Topic; Female; Gonadotropin-Releasing Hormone; Humans; Male; Nafarelin; Prognosis; Puberty, Precocious; Triptorelin Pamoate | 1993 |
Ovarian hyperstimulation: effects of GnRH analogues. Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome?
Topics: Buserelin; Chorionic Gonadotropin; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Triptorelin Pamoate | 1996 |
The gonadotrophin-releasing hormone antagonist ganirelix--history and introductory data.
Topics: Adolescent; Adult; Buserelin; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Leuprolide; Male; Ovulation Induction; Pregnancy; Triptorelin Pamoate | 2002 |
Cost-effectiveness analysis of LHRH agonists in the treatment of metastatic prostate cancer in Italy.
Topics: Aged; Antineoplastic Agents, Hormonal; Buserelin; Cost-Benefit Analysis; Decision Trees; Drug Costs; Gonadotropin-Releasing Hormone; Goserelin; Humans; Italy; Leuprolide; Male; Models, Econometric; Proportional Hazards Models; Prostatic Neoplasms; Survival Analysis; Triptorelin Pamoate | 2011 |
Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
Topics: Buserelin; Clinical Protocols; Drug Administration Schedule; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Live Birth; Luteinizing Hormone; Ovulation Induction; Pituitary Gland; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted; Triptorelin Pamoate | 2011 |
Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
Topics: Buserelin; Clinical Protocols; Drug Administration Schedule; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Live Birth; Luteinizing Hormone; Ovulation Induction; Pituitary Gland; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted; Triptorelin Pamoate | 2015 |
Current Medical Strategies in the Prevention of Ovarian Hyperstimulation Syndrome
Topics: Aminoquinolines; Bromocriptine; Buserelin; Cabergoline; Chorionic Gonadotropin; Dopamine Agonists; Ergolines; Estradiol; Estrogens; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone; Progestins; Triptorelin Pamoate | 2017 |
19 trial(s) available for buserelin and trelstar
Article | Year |
---|---|
Randomized trial of three luteinizing hormone-releasing hormone analogues used for ovarian stimulation in an in vitro fertilization program.
Topics: Buserelin; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Ovarian Follicle; Ovary; Stimulation, Chemical; Time Factors; Triptorelin Pamoate | 1992 |
The use of long-acting gonadotropin-releasing hormone agonist (GnRH-a; decapeptyl) and gonadotropins versus short-acting GnRH-a (buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilization (IVF).
Topics: Adult; Buserelin; Delayed-Action Preparations; Drug Therapy, Combination; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Luteolytic Agents; Menotropins; Ovary; Ovulation Induction; Pregnancy; Time Factors; Triptorelin Pamoate | 1991 |
[Ovarian stimulation for in vitro fertilization using LHRH agonists: comparison of plasma and intra-follicular hormone profiles using "short" and "long" protocols].
Topics: Adult; Androstenedione; Buserelin; Clinical Protocols; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Luteinizing Hormone; Luteolytic Agents; Ovulation Induction; Pregnancy; Pregnancy Outcome; Progesterone; Prolactin; Retrospective Studies; Testosterone; Triptorelin Pamoate | 1990 |
[GnRH-analogs in the therapy of uterine myomatosis].
Topics: Adult; Antineoplastic Agents; Buserelin; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Middle Aged; Triptorelin Pamoate; Uterine Neoplasms | 1990 |
Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.
Topics: Aged; Buserelin; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Prostatic Neoplasms; Triptorelin Pamoate | 1985 |
Gonadotropin-releasing hormone analogs and prostatic cancer.
Topics: Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Clinical Trials as Topic; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Prostatic Neoplasms; Triptorelin Pamoate | 1988 |
Endocrine and clinical evaluation of 107 patients with advanced prostatic carcinoma under long-term pernasal buserelin or intramuscular decapeptyl depot treatment.
Topics: Adenocarcinoma; Administration, Intranasal; Antineoplastic Agents; Biomarkers, Tumor; Buserelin; Clinical Trials as Topic; Gonadotropin-Releasing Hormone; Humans; Injections, Intramuscular; Lymphatic Metastasis; Male; Neoplasm Staging; Prostatic Neoplasms; Time Factors; Triptorelin Pamoate | 1988 |
Advantages of the combination therapy in previously untreated and treated patients with advanced prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents; Buserelin; Clinical Trials as Topic; Combined Modality Therapy; Diethylstilbestrol; Flutamide; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Neoplasm Staging; Orchiectomy; Prostatic Neoplasms; Triptorelin Pamoate | 1986 |
Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrog
Topics: Adolescent; Age Factors; Androgen Antagonists; Buserelin; Child; Child, Preschool; Cyproterone Acetate; Delayed-Action Preparations; Drug Therapy, Combination; Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone; Hormones; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Luteinizing Hormone; Luteolytic Agents; Puberty; Puberty, Precocious; Triptorelin Pamoate | 1995 |
Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments.
Topics: Administration, Intranasal; Body Height; Buserelin; Child; Delayed-Action Preparations; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Puberty, Precocious; Triptorelin Pamoate | 1994 |
Prospective randomized study of D-Trp6-LHRH versus buserelin in long desensitization protocols for medically assisted conception cycles.
Topics: Adult; Buserelin; Delayed-Action Preparations; Down-Regulation; Drug Administration Schedule; Embryonic and Fetal Development; Female; Fertilization in Vitro; Hormones; Humans; Ovarian Follicle; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Prospective Studies; Time Factors; Triptorelin Pamoate | 1994 |
Should gonadotropin-releasing hormone down-regulation therapy be routine in in vitro fertilization?
Topics: Adult; Buserelin; Clomiphene; Female; Fertilization in Vitro; Humans; Infertility, Female; Male; Menotropins; Ovulation Induction; Pregnancy; Pregnancy Outcome; Prospective Studies; Triptorelin Pamoate | 1994 |
The long-acting gonadotropin-releasing hormone analogues impaired the implantation rate.
Topics: Adult; Buserelin; Cross-Over Studies; Embryo Implantation; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Humans; Progesterone; Prospective Studies; Triptorelin Pamoate | 1996 |
Controlled, reversible suppression of estrous cycles in beef heifers and cows using agonists of gonadotropin-releasing hormone.
Topics: Animals; Buserelin; Cattle; Dose-Response Relationship, Drug; Drug Implants; Estrus; Female; Gonadotropin-Releasing Hormone; Progesterone; Triptorelin Pamoate | 1996 |
Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.
Topics: Adolescent; Body Height; Bone Density; Buserelin; Child; Child, Preschool; Female; Gonadotropin-Releasing Hormone; Humans; Puberty, Precocious; Regression Analysis; Triptorelin Pamoate | 1998 |
Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization.
Topics: Adult; Buserelin; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Male; Ovulation Induction; Pregnancy; Prospective Studies; Triptorelin Pamoate | 1999 |
Effects of buserelin injection and deslorelin (GnRH-agonist) implants on plasma progesterone, LH, accessory CL formation, follicle and corpus luteum dynamics in Holstein cows.
Topics: Animals; Buserelin; Cattle; Corpus Luteum; Drug Implants; Estrus; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Humans; Infant; Kinetics; Luteinizing Hormone; Ovarian Follicle; Ovulation Induction; Progesterone; Triptorelin Pamoate | 1998 |
Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916).
Topics: Adult; Buserelin; Delayed-Action Preparations; Double-Blind Method; Embryo Transfer; Female; Fertility Agents, Female; Humans; Luteolytic Agents; Ovulation Induction; Pregnancy; Sperm Injections, Intracytoplasmic; Treatment Outcome; Triptorelin Pamoate | 2007 |
Ovulation induced by mucosa vaginal absorption of buserelin and triptorelin in rabbit.
Topics: Animals; Buserelin; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Luteolytic Agents; Male; Mucous Membrane; Ovulation; Pregnancy; Pregnancy Rate; Rabbits; Random Allocation; Triptorelin Pamoate; Vagina | 2007 |
80 other study(ies) available for buserelin and trelstar
Article | Year |
---|---|
Dissociation between release and gene expression of gonadotropin alpha-subunit in gonadotropin-releasing hormone-stimulated alpha T3-1 cell line.
Topics: Animals; Blotting, Northern; Buserelin; Gene Expression; Glycoprotein Hormones, alpha Subunit; Gonadotropin-Releasing Hormone; Ionomycin; Mice; Mice, Transgenic; Phosphatidylinositols; Receptors, LHRH; RNA, Messenger; Tetradecanoylphorbol Acetate; Triptorelin Pamoate; Tumor Cells, Cultured | 1992 |
Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Buserelin; Cell Division; Dose-Response Relationship, Drug; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Kinetics; Receptors, LHRH; Triptorelin Pamoate | 1992 |
Differential effects of LHRH and somatostatin analogs on human breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Buserelin; Carcinoma; Cell Division; Estrogens; Gonadotropin-Releasing Hormone; Goserelin; Hormones; Humans; In Vitro Techniques; Somatostatin; Triptorelin Pamoate; Tumor Cells, Cultured | 1992 |
[Prognostic value of preovulatory elevations of plasma progesterone during in vitro fertilization using LHRH agonists in a long protocol].
Topics: Buserelin; Clinical Protocols; Drug Therapy, Combination; Female; Fertilization in Vitro; Humans; Infertility, Female; Luteolytic Agents; Menotropins; Predictive Value of Tests; Pregnancy; Pregnancy Outcome; Progesterone; Prognosis; Retrospective Studies; Triptorelin Pamoate | 1992 |
Influence of ovarian cysts on the results of in vitro fertilization.
Topics: Buserelin; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Leuprolide; Luteinizing Hormone; Menotropins; Ovarian Cysts; Ovarian Follicle; Pregnancy; Retrospective Studies; Triptorelin Pamoate | 1992 |
Pre-surgical treatment of uterine myomas with LH-RH agonists.
Topics: Administration, Inhalation; Adult; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Chemotherapy, Adjuvant; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Injections, Intramuscular; Leiomyoma; Leuprolide; Luteinizing Hormone; Middle Aged; Triptorelin Pamoate; Uterine Neoplasms | 1992 |
Gonadotropin-releasing hormone (GnRH) action on uterine leiomyomata is not mediated by uterine GnRH receptors.
Topics: Adult; Buserelin; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Receptors, LHRH; Triptorelin Pamoate; Uterine Neoplasms | 1991 |
Platelet-activating factor-acether is a component of human follicular fluid.
Topics: Adult; Animals; Buserelin; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Menotropins; Oocytes; Platelet Activating Factor; Platelet Aggregation; Rabbits; Triptorelin Pamoate | 1991 |
Pulmonary endometriosis: conservative treatment with GnRH agonists.
Topics: Administration, Intranasal; Adult; Antineoplastic Agents; Buserelin; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hemoptysis; Hormones; Humans; Leuprolide; Lung Neoplasms; Pneumothorax; Triptorelin Pamoate | 1991 |
Treatment with different GnRH analogues in women: preliminary evidence for disparant effects on serum androgen concentrations.
Topics: Adult; Androgens; Buserelin; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Triptorelin Pamoate | 1991 |
Delayed embryo transfer in an in-vitro fertilization programme: how to avoid working on Sunday.
Topics: Buserelin; Embryo Transfer; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Infertility; Menotropins; Ovary; Ovulation Induction; Pregnancy; Pregnancy Outcome; Triptorelin Pamoate | 1991 |
[Differential effects of GnRH analogs on androgen concentrations in females].
Topics: Adult; Androgens; Antineoplastic Agents; Buserelin; Drug Implants; Endometriosis; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Injections, Intramuscular; Leiomyoma; Luteinizing Hormone; Triptorelin Pamoate; Uterine Neoplasms | 1991 |
Gonadotropin-releasing hormone agonists induce meiotic maturation and degeneration of oocytes in the in vitro perfused rabbit ovary.
Topics: Animals; Buserelin; Delayed-Action Preparations; Female; Gonadotropin-Releasing Hormone; Hormones; Leuprolide; Meiosis; Oocytes; Ovary; Rabbits; Reference Values; Triptorelin Pamoate | 1991 |
Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention.
Topics: Buserelin; Estradiol; Europe; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Ovarian Diseases; Ovary; Pregnancy; Pregnancy Outcome; Risk Factors; Syndrome; Triptorelin Pamoate | 1990 |
Maturation of the hypothalamic control of pulsatile gonadotropin-releasing hormone secretion at onset of puberty: II. Reduced potency of an inhibitory autofeedback.
Topics: Animals; Arginine Vasopressin; Buserelin; Feedback; Gonadotropin-Releasing Hormone; Growth Hormone-Releasing Hormone; Hypothalamus; Male; N-Methylaspartate; Organ Culture Techniques; Potassium; Rats; Rats, Inbred Strains; Sexual Maturation; Thyrotropin-Releasing Hormone; Triptorelin Pamoate; Veratridine | 1990 |
Adverse neurological symptoms after gonadotropin-releasing hormone analog therapy for in vitro fertilization cycles.
Topics: Adult; Buserelin; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Luteolytic Agents; Nervous System Diseases; Ovulation Induction; Triptorelin Pamoate | 1990 |
Ovarian response and pregnancy rates in in vitro fertilization, gamete intrafallopian transfer, and in vivo fertilization therapies after combined gonadotropin-releasing hormone agonist/human menopausal gonadotropin stimulation.
Topics: Adult; Buserelin; Female; Fertilization; Fertilization in Vitro; Gamete Intrafallopian Transfer; Gonadotropin-Releasing Hormone; Humans; Menotropins; Ovary; Pregnancy; Triptorelin Pamoate | 1990 |
Induction of pharmacological hypogonadotropism using gonadotropin-releasing hormone agonists in patients undergoing controlled ovarian stimulation.
Topics: Adult; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypogonadism; Luteinizing Hormone; Ovary; Pituitary Gland; Prolactin; Testosterone; Triptorelin Pamoate | 1990 |
[True precocious puberty in girl. Therapy with LHRH analogs].
Topics: Buserelin; Child; Child, Preschool; Female; Gonadotropin-Releasing Hormone; Humans; Luteolytic Agents; Puberty, Precocious; Triptorelin Pamoate | 1990 |
LH-RH agonist monotherapy in patients with carcinoma of the prostate and reflections on the so-called total androgen blockade.
Topics: Antineoplastic Agents; Buserelin; Carcinoma; Gonadotropin-Releasing Hormone; Humans; Male; Neoplasm Recurrence, Local; Orchiectomy; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate | 1990 |
Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy.
Topics: Buserelin; Embryo Transfer; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Ovarian Cysts; Ovulation Induction; Pregnancy; Triptorelin Pamoate | 1989 |
Influence of different stimulation treatments on oocyte characteristics and in-vitro fertilizing ability.
Topics: Adult; Buserelin; Clomiphene; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Norethindrone; Oocytes; Ovulation Induction; Triptorelin Pamoate | 1989 |
Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormone.
Topics: Adult; Buserelin; Embryo Transfer; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Oocytes; Ovulation Induction; Pregnancy; Triptorelin Pamoate | 1989 |
[GnRH agonist/hMG stimulation in gamete intrafallopian transfer (GIFT)].
Topics: Administration, Intranasal; Adult; Buserelin; Combined Modality Therapy; Delayed-Action Preparations; Drug Administration Schedule; Female; Follow-Up Studies; Gamete Intrafallopian Transfer; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Outcome; Triptorelin Pamoate | 1989 |
[Increased incidence of ovarian hyperstimulation syndrome following combined GnRH agonist/hMG therapy].
Topics: Buserelin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Menotropins; Ovarian Cysts; Ovary; Ovulation Induction; Pituitary Hormone-Releasing Hormones; Pregnancy; Risk Factors; Syndrome; Triptorelin Pamoate | 1989 |
[Therapy with LHRH analogs in a 41-year-old patient with metastatic breast cancer].
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Buserelin; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Femoral Neoplasms; Gonadotropin-Releasing Hormone; Humans; Injections, Subcutaneous; Male; Tamoxifen; Triptorelin Pamoate | 1989 |
Prolactin-lowering effect of luteinizing hormone-releasing hormone agonist administration in prolactinoma patients.
Topics: Adult; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Pituitary Neoplasms; Progesterone; Prolactin; Prolactinoma; Testosterone; Triptorelin Pamoate | 1989 |
Suppression with gonadotropin-releasing hormone analogues prior to stimulation with gonadotropins: comparison of three protocols.
Topics: Adult; Age Factors; Buserelin; Clinical Protocols; Delayed-Action Preparations; Depression, Chemical; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Menotropins; Ovary; Ovulation Induction; Pituitary Gland; Triptorelin Pamoate | 1989 |
[Combined GnRH agonist/hMG therapy and ovarian overstimulation syndrome].
Topics: Buserelin; Combined Modality Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Hypogonadism; Infertility, Female; Menotropins; Ovulation Induction; Pregnancy; Triptorelin Pamoate | 1989 |
[Combined GnRH analogs/hMG/hCG treatment].
Topics: Buserelin; Chorionic Gonadotropin; Combined Modality Therapy; Embryo Transfer; Female; Fertilization in Vitro; Gamete Intrafallopian Transfer; Gonadotropin-Releasing Hormone; Humans; Menotropins; Ovulation Induction; Triptorelin Pamoate | 1989 |
Clinical appreciation of LHRH analogue formulations.
Topics: Buserelin; Delayed-Action Preparations; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Nafarelin; Triptorelin Pamoate | 1989 |
Endocrine profiles and luteal function during GnRH-analogue/HMG therapy.
Topics: Anovulation; Buserelin; Chorionic Gonadotropin; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteal Phase; Luteinizing Hormone; Luteolytic Agents; Menotropins; Ovulation Induction; Progesterone; Testosterone; Triptorelin Pamoate | 1989 |
[GnRH agonists in the ovulation stimulation scheme for in vitro fertilization].
Topics: Buserelin; Female; Fertilization; Gonadotropin-Releasing Hormone; Humans; Ovulation Induction; Pituitary Hormone-Releasing Hormones; Triptorelin Pamoate | 1989 |
Gonadotropin-releasing hormone specific binding sites in uterine leiomyomata.
Topics: Adult; Buserelin; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Middle Aged; Molecular Weight; Receptors, LHRH; Thyrotropin-Releasing Hormone; Triptorelin Pamoate; Uterine Neoplasms; Uterus | 1988 |
Inhibition of testicular androgen biosynthesis by chronic administration of a potent LHRH agonist in adult men.
Topics: Administration, Intranasal; Adult; Androgens; Buserelin; Dose-Response Relationship, Drug; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Orchiectomy; Prostatic Neoplasms; Testis; Testosterone; Time Factors; Triptorelin Pamoate | 1985 |
[Treatment of carcinoma of the prostate with analogs of LHRH].
Topics: Androgen Antagonists; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Carcinoma; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Prostatic Neoplasms; Triptorelin Pamoate | 1986 |
Metastatic prostate cancer under long term pernasal buserelin or intramuscular decapeptyl depot treatment.
Topics: Administration, Intranasal; Antineoplastic Agents; Biomarkers, Tumor; Buserelin; Delayed-Action Preparations; Gonadotropin-Releasing Hormone; Humans; Injections, Intramuscular; Luteinizing Hormone; Male; Neoplasm Metastasis; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate | 1987 |
Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas.
Topics: Adenoma; Adult; Buserelin; Drug Evaluation; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Male; Middle Aged; Neoplasm Recurrence, Local; Pituitary Neoplasms; Stimulation, Chemical; Testosterone; Time Factors; Triptorelin Pamoate | 1988 |
Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program.
Topics: Adult; Buserelin; Cell Count; Chorionic Gonadotropin; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Menotropins; Oocytes; Ovulation Induction; Pregnancy; Triptorelin Pamoate | 1988 |
Abolishment of the positive feedback mechanism: a criterion for temporary medical hypophysectomy by LH-RH agonist.
Topics: Administration, Intranasal; Buserelin; Drug Administration Schedule; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypophysectomy; Hypophysectomy, Chemical; Infertility, Female; Injections, Subcutaneous; Luteinizing Hormone; Luteolytic Agents; Polycystic Ovary Syndrome; Triptorelin Pamoate | 1987 |
The effect of different LH-RH agonists on the levels of immunoreactive gonadotropins.
Topics: Buserelin; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Luteolytic Agents; Ovary; Pituitary Gland; Pituitary Hormone-Releasing Hormones; Triptorelin Pamoate | 1988 |
Pulsatile release of gonadotropin-releasing hormone (GnRH) from the rat hypothalamus in vitro: calcium and glucose dependency and inhibition by superactive GnRH analogs.
Topics: Animals; Buserelin; Calcium; Egtazic Acid; Gallopamil; Glucose; Gonadotropin-Releasing Hormone; Hypothalamus; Male; Periodicity; Rats; Rats, Inbred Strains; Triptorelin Pamoate; Veratridine | 1987 |
Long-term endocrine profiles of prostatic carcinoma patients under pernasal as well as intramuscular Gn-RH analogue treatment.
Topics: Administration, Intranasal; Buserelin; Dihydrotestosterone; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Injections, Intramuscular; Male; Prostatic Neoplasms; Testosterone; Time Factors; Triptorelin Pamoate | 1985 |
Long term treatment with luteinising hormone releasing hormone agonists and maintenance of serum testosterone to castration concentrations.
Topics: Bone Neoplasms; Buserelin; Flutamide; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Radioimmunoassay; Testosterone; Time Factors; Triptorelin Pamoate | 1985 |
Effect of LHRH agonists and antagonists in male and female bonnet monkeys (Macaca radiata).
Topics: Animals; Buserelin; Chorionic Gonadotropin; Circadian Rhythm; Female; Gonadotropin-Releasing Hormone; Macaca; Macaca radiata; Male; Pregnancy; Testosterone; Triptorelin Pamoate | 1985 |
Antifertility effects of LHRH agonists in the male rat and inhibition of testicular steroidogenesis in man.
Topics: Administration, Intranasal; Adult; Androgens; Animals; Buserelin; Circadian Rhythm; Dose-Response Relationship, Drug; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Leydig Cells; Luteinizing Hormone; Male; Progestins; Rats; Receptors, Cell Surface; Receptors, LH; Receptors, LHRH; Spermatogenesis; Testis; Triptorelin Pamoate | 1980 |
Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.
Topics: Buserelin; Carcinoma; Estradiol; Gonadotropin-Releasing Hormone; Humans; Male; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate | 1982 |
The use of recombinant FSH for ovulation induction.
Topics: Buserelin; Drug Therapy, Combination; Female; Follicle Stimulating Hormone; Humans; Ovulation Induction; Recombinant Proteins; Triptorelin Pamoate | 1994 |
Human placental gonadotrophin-releasing hormone (GnRH) binding sites: III. Changes in GnRH binding levels with stage of gestation.
Topics: Buserelin; Cell Membrane; Chorionic Villi; Female; Gonadotropin-Releasing Hormone; Humans; Iodine Radioisotopes; Pregnancy; Receptors, LHRH; Time Factors; Triptorelin Pamoate | 1994 |
Follicle cyst formation after administration of different gonadotrophin-releasing hormone analogues for assisted reproduction.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Menotropins; Ovarian Cysts; Pregnancy; Triptorelin Pamoate | 1994 |
Variations in pituitary-gonadal suppression during intranasal buserelin and intramuscular depot-triptorelin therapy for central precocious puberty. Belgian Study Group for Pediatric Endocrinology.
Topics: Administration, Intranasal; Body Height; Bone Development; Buserelin; Delayed-Action Preparations; Female; Follicle Stimulating Hormone; Humans; Injections, Intramuscular; Luteinizing Hormone; Male; Pituitary Gland; Puberty, Precocious; Triptorelin Pamoate | 1994 |
Functional differentiation in progesterone secretion by granulosa versus cumulus cells in the human preovulatory follicle and the effect of different induction of ovulation protocols.
Topics: Adult; Buserelin; Cells, Cultured; Chorionic Gonadotropin; Clomiphene; Female; Granulosa Cells; Humans; Menotropins; Ovarian Follicle; Ovulation Induction; Progesterone; Triptorelin Pamoate | 1993 |
Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. The German-Dutch Precocious Puberty Study Group.
Topics: Body Height; Bone Development; Buserelin; Child; Estradiol; Female; Gonadotropin-Releasing Hormone; Growth; Humans; Luteinizing Hormone; Ovary; Pituitary Gland; Puberty, Precocious; Triptorelin Pamoate | 1993 |
Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women.
Topics: Adult; Buserelin; Delayed-Action Preparations; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Luteinizing Hormone; Triptorelin Pamoate | 1993 |
Does elective cryopreservation of all embryos from women at risk of ovarian hyperstimulation syndrome reduce the incidence of the condition?
Topics: Adult; Buserelin; Cryopreservation; Embryo, Mammalian; Estradiol; Female; Fertilization in Vitro; Gamete Intrafallopian Transfer; Gonadotropin-Releasing Hormone; Humans; Incidence; Infertility, Female; Middle Aged; Ovarian Hyperstimulation Syndrome; Pregnancy; Risk Factors; Triptorelin Pamoate | 1993 |
More basic isoforms of serum gonadotropins during gonadotropin-releasing hormone agonist therapy in pubertal children.
Topics: Adolescent; Buserelin; Child; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Puberty; Triptorelin Pamoate | 1996 |
Uterine leiomyomata and sterility: therapy with gonadotropin-releasing hormone agonists and leiomyomectomy.
Topics: Administration, Intranasal; Adult; Antineoplastic Agents, Hormonal; Buserelin; Chemotherapy, Adjuvant; Female; Gonadotropin-Releasing Hormone; Goserelin; Hormones; Humans; Infertility, Female; Injections, Intramuscular; Leiomyoma; Leuprolide; Nafarelin; Pregnancy; Pregnancy Rate; Retrospective Studies; Time Factors; Triptorelin Pamoate; Uterine Neoplasms | 1997 |
Comparison of a blocking vs. a flare-up protocol in poor responders with a normal and abnormal clomiphene citrate challenge test.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Clomiphene; Desogestrel; Embryo Transfer; Estradiol; Ethinyl Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gamete Intrafallopian Transfer; Humans; Infertility; Menotropins; Ovulation Induction; Pregnancy; Triptorelin Pamoate | 1997 |
Prospective evaluation of endometrial thickness as a predictor of pituitary down-regulation after gonadotropin-releasing hormone analogue administration in an in vitro fertilization program.
Topics: Adult; Buserelin; Endometrium; Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Nafarelin; Pituitary Gland; Prospective Studies; Sensitivity and Specificity; Triptorelin Pamoate; Ultrasonography | 1998 |
Degradation kinetics of three gonadorelin analogues: developing a method for calculating epimerization parameters.
Topics: Buffers; Buserelin; Chromatography, High Pressure Liquid; Gonadotropin-Releasing Hormone; Goserelin; Hydrogen-Ion Concentration; Kinetics; Models, Chemical; Protein Conformation; Temperature; Triptorelin Pamoate | 1998 |
Influence of deslorelin (GnRH-agonist) implant on plasma progesterone, first wave dominant follicle and pregnancy in dairy cattle.
Topics: Animals; Buserelin; Cattle; Corpus Luteum; Drug Implants; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Luteolysis; Ovarian Follicle; Ovary; Pregnancy; Progesterone; Triptorelin Pamoate; Ultrasonography | 1998 |
Gonadotropin-releasing hormone analogues in the management of precocious puberty.
Topics: Body Height; Buserelin; Child; Female; Gonadotropin-Releasing Hormone; Humans; Male; Menstrual Cycle; Ovulation; Puberty, Precocious; Triptorelin Pamoate | 2000 |
Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues.
Topics: Adolescent; Body Height; Bone Density; Buserelin; Dihydrotestosterone; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Puberty, Precocious; Sperm Count; Sperm Motility; Testis; Testosterone; Triptorelin Pamoate | 2000 |
End results in central precocious puberty with GnRH analog treatment: the data of the Italian Study Group for Physiopathology of Puberty.
Topics: Aerosols; Body Height; Bone Density; Bone Development; Brain Diseases; Buserelin; Child; Delayed-Action Preparations; Female; Gonadotropin-Releasing Hormone; Humans; Injections, Intramuscular; Puberty, Precocious; Retrospective Studies; Treatment Outcome; Triptorelin Pamoate | 2000 |
Comparative analysis of different puberty inhibiting mechanisms of two GnRH agonists and the GnRH antagonist cetrorelix using a female rat model.
Topics: Animals; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Follicle Stimulating Hormone, beta Subunit; Gene Expression; Glycoprotein Hormones, alpha Subunit; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Organ Size; Ovary; Pituitary Gland; Rats; Rats, Sprague-Dawley; Receptors, LHRH; Sexual Maturation; Triptorelin Pamoate | 2000 |
Serum inhibin A and inhibin B in central precocious puberty before and during treatment with GnRH agonists.
Topics: Buserelin; Child; Child, Preschool; Cyproterone Acetate; Female; Fertility; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Inhibins; Prostatic Secretory Proteins; Puberty, Precocious; Triptorelin Pamoate | 2000 |
[Comparison of different protocols of ovulation induction, by GnRH agonists and chorionic gonadotropin].
Topics: Adult; Buserelin; Chorionic Gonadotropin; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteal Phase; Luteinizing Hormone; Nafarelin; Ovulation Induction; Pregnancy; Triptorelin Pamoate | 2001 |
The effect of GnRH analogs on urinary incontinence after ablation of the ovaries in dogs.
Topics: Animals; Buserelin; Dog Diseases; Dogs; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Leuprolide; Luteinizing Hormone; Ovariectomy; Phenylpropanolamine; Sympathomimetics; Triptorelin Pamoate; Urinary Incontinence | 2003 |
Evidence for LHRH-receptor expression in human airway epithelial (Calu-3) cells and its role in the transport of an LHRH agonist.
Topics: 2,4-Dinitrophenol; Animals; Biological Transport; Blotting, Western; Buserelin; Cattle; Cell Line; Electric Impedance; Epithelial Cells; Fluorescent Antibody Technique; Gene Expression; Humans; Oligoribonucleotides, Antisense; Rats; Receptors, LHRH; Respiratory System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Temperature; Time Factors; Triptorelin Pamoate | 2004 |
Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction.
Topics: Adult; Area Under Curve; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Ovulation Induction; Retrospective Studies; Sperm Injections, Intracytoplasmic; Triptorelin Pamoate | 2005 |
The development of a testosterone stimulation test in the Virginia opossum (Didelphis virginiana) and its use in evaluating deslorelin contraception.
Topics: Animals; Buserelin; Chorionic Gonadotropin; Contraception; Contraceptive Agents, Male; Diagnostic Techniques, Endocrine; Drug Evaluation, Preclinical; Drug Implants; Male; Opossums; Organ Size; Testis; Testosterone; Triptorelin Pamoate | 2008 |
Basal testosterone concentrations after the application of a slow-release GnRH agonist implant are associated with a loss of response to buserelin, a short-term GnRH agonist, in the tom cat.
Topics: Animals; Buserelin; Castration; Cats; Contraception; Down-Regulation; Drug Implants; Gonadotropin-Releasing Hormone; Male; Pituitary Gland; Receptors, LHRH; Testosterone; Triptorelin Pamoate | 2013 |
Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Cohort Studies; Corpus Luteum; Estradiol; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Ovarian Hyperstimulation Syndrome; Ovary; Ovulation Induction; Quebec; Retrospective Studies; Risk Factors; Severity of Illness Index; Triptorelin Pamoate; Turkey; Ultrasonography | 2013 |
[Role of ovarian suppression in the combined treatment of breast cancer patients in premenopause].
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Leuprolide; Middle Aged; Ovary; Perimenopause; Premenopause; Survival Analysis; Treatment Outcome; Triptorelin Pamoate | 2013 |
Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort.
Topics: Aged; Androgen Antagonists; Androstenes; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Cohort Studies; Disease-Free Survival; Docetaxel; Flutamide; Humans; Leuprolide; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nitriles; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Taxoids; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate | 2015 |
Reversible estrous cycle suppression in prepubertal female rabbits treated with slow-release deslorelin implants.
Topics: Animals; Buserelin; Delayed-Action Preparations; Drug Implants; Estrous Cycle; Female; Gonadotropin-Releasing Hormone; Ovary; Ovulation Induction; Progesterone; Pseudopregnancy; Rabbits; Sexual Maturation; Triptorelin Pamoate | 2016 |
Histopathologic examination of the genital tract in rabbits treated once or twice with a slow-release deslorelin implant for reversible suppression of ovarian function.
Topics: Animals; Buserelin; Delayed-Action Preparations; Drug Implants; Enzyme Inhibitors; Female; Genitalia, Female; Hysterectomy; Ovariectomy; Ovary; Ovulation; Progesterone; Rabbits; Triptorelin Pamoate | 2016 |
INN Common stem: -relin.
Topics: Antineoplastic Agents, Hormonal; Buserelin; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Nafarelin; Terminology as Topic; Triptorelin Pamoate | 2017 |
Single injection of triptorelin or buserelin acetate in saline solution induces ovulation in mares the same as a single injection of hCG.
Topics: Animals; Breeding; Buserelin; Chorionic Gonadotropin; Female; Fertility Agents, Female; Horses; Injections, Subcutaneous; Ovulation Induction; Triptorelin Pamoate | 2020 |
Cardiovascular adverse events-related to GnRH agonists and GnRH antagonists: analysis of real-life data from Eudra-Vigilance and Food and Drug Administration databases entries.
Topics: Androgen Antagonists; Buserelin; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Prostatic Neoplasms; Triptorelin Pamoate; United States; United States Food and Drug Administration | 2023 |